213 related articles for article (PubMed ID: 38206030)
1. Gold(I) ion and the phosphine ligand are necessary for the anti-
Ma CI; Tirtorahardjo JA; Schweizer SS; Zhang J; Fang Z; Xing L; Xu M; Herman DA; Kleinman MT; McCullough BS; Barrios AM; Andrade RM
Microbiol Spectr; 2024 Feb; 12(2):e0296823. PubMed ID: 38206030
[TBL] [Abstract][Full Text] [Related]
2. Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis.
Andrade RM; Chaparro JD; Capparelli E; Reed SL
PLoS Negl Trop Dis; 2014; 8(7):e2973. PubMed ID: 25079790
[TBL] [Abstract][Full Text] [Related]
3. Next Generation Gold Drugs and Probes: Chemistry and Biomedical Applications.
Mertens RT; Gukathasan S; Arojojoye AS; Olelewe C; Awuah SG
Chem Rev; 2023 May; 123(10):6612-6667. PubMed ID: 37071737
[TBL] [Abstract][Full Text] [Related]
4. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
5. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
[No Abstract] [Full Text] [Related]
6. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
[TBL] [Abstract][Full Text] [Related]
7. Antiprotozoal activity of auranofin on Trypanosoma cruzi, Leishmania tropica and Toxoplasma gondii: in vitro and ex vivo study.
Yıldırım A; Özbilgin A; Yereli K
Trans R Soc Trop Med Hyg; 2023 Oct; 117(10):733-740. PubMed ID: 37377375
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis.
Furst DE
Pharmacotherapy; 1983; 3(5):284-98. PubMed ID: 6417628
[TBL] [Abstract][Full Text] [Related]
9. Auranofin Resistance in
Ma CI; Tirtorahardjo JA; Jan S; Schweizer SS; Rosario SAC; Du Y; Zhang JJ; Morrissette NS; Andrade RM
Front Cell Infect Microbiol; 2021; 11():618994. PubMed ID: 33816332
[TBL] [Abstract][Full Text] [Related]
10. Repurposing auranofin for treatment of Experimental Cerebral Toxoplasmosis.
Abou-El-Naga IF; Mogahed NMFH
Acta Parasitol; 2021 Sep; 66(3):827-836. PubMed ID: 33555553
[TBL] [Abstract][Full Text] [Related]
11. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human neutrophil collagenase by gold(I) salts used in chrysotherapy.
Mallya SK; Van Wart HE
Biochem Biophys Res Commun; 1987 Apr; 144(1):101-8. PubMed ID: 3034241
[TBL] [Abstract][Full Text] [Related]
13. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate.
Davis P; Landon M
J Rheumatol; 1985 Jun; 12(3):622. PubMed ID: 3930724
[No Abstract] [Full Text] [Related]
14. Comparative safety and efficacy of auranofin and parenteral gold compounds: a review.
Horton RJ
Scand J Rheumatol Suppl; 1983; 51():100-10. PubMed ID: 6426044
[TBL] [Abstract][Full Text] [Related]
15. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
Harth M; McCain GA; Orange JF
J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
[TBL] [Abstract][Full Text] [Related]
16. Auranofin.
Davis P
Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
[TBL] [Abstract][Full Text] [Related]
17. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
Batlle Gualda E
Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
[No Abstract] [Full Text] [Related]
18. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
Batlle Gualda E
Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
[No Abstract] [Full Text] [Related]
19. Ploidity and cell cycle progression during treatment with gold chloride, auranofin and sodium aurothiomalate. Studies on a human epithelial cell line and its sub-strains made resistant to the antiproliferative effects of these gold compounds.
Glennås A; Rugstad HE
Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 49(4):385-93. PubMed ID: 2867637
[TBL] [Abstract][Full Text] [Related]
20. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
